Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Change in Accured Expenses (2023 - 2025)

Fractyl Health's Change in Accured Expenses history spans 3 years, with the latest figure at -$169000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses fell 106.46% year-over-year to -$169000.0, compared with a TTM value of $414000.0 through Dec 2025, down 92.68%, and an annual FY2025 reading of $414000.0, down 92.68% over the prior year.
  • Change in Accured Expenses for Q4 2025 was -$169000.0 at Fractyl Health, up from -$811000.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $2.9 million in Q1 2024, with the low at -$1.8 million in Q2 2024.
  • Average Change in Accured Expenses over 3 years is $550916.7, with a median of $490500.0 recorded in 2023.
  • Year-over-year, Change in Accured Expenses skyrocketed 2430.77% in 2024 and then tumbled 141.08% in 2025.
  • Tracing GUTS's Change in Accured Expenses over 3 years: stood at $367000.0 in 2023, then soared by 613.35% to $2.6 million in 2024, then crashed by 106.46% to -$169000.0 in 2025.
  • Per Business Quant, the three most recent readings for GUTS's Change in Accured Expenses are -$169000.0 (Q4 2025), -$811000.0 (Q3 2025), and $614000.0 (Q2 2025).